These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9166093)

  • 1. Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine.
    Thatcher N; Hopwood P; Anderson H
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S8-13. PubMed ID: 9166093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer.
    Anderson H; Hopwood P; Stephens RJ; Thatcher N; Cottier B; Nicholson M; Milroy R; Maughan TS; Falk SJ; Bond MG; Burt PA; Connolly CK; McIllmurray MB; Carmichael J
    Br J Cancer; 2000 Aug; 83(4):447-53. PubMed ID: 10945489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
    Noble S; Goa KL
    Drugs; 1997 Sep; 54(3):447-72. PubMed ID: 9279506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial.
    Gridelli C; Perrone F; Gallo C; Rossi A; Barletta E; Barzelloni ML; Creazzola S; Gatani T; Fiore F; Guida C; Scognamiglio F
    Anticancer Res; 1999; 19(5C):4535-8. PubMed ID: 10650806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.
    Bianco V; Rozzi A; Tonini G; Santini D; Magnolfi E; Vincenzi B; D'Angelillo R; Marchei P
    Anticancer Res; 2002; 22(5):3053-6. PubMed ID: 12530041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine in non-small cell lung cancer.
    Sørensen JB
    Lung Cancer; 1995 Apr; 12 Suppl 1():S173-5. PubMed ID: 7551926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chemotherapy (CT) and supportive care (SC) in advanced non-small cell lung cancer (NSCLC).
    Thatcher N
    Lung Cancer; 2002 Dec; 38 Suppl 3():S71-3. PubMed ID: 12468151
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
    Chen YM; Chen MC; Tsai CM; Perng RP
    Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer.
    van Putten JW; Baas P; Codrington H; Kwa HB; Muller M; Aaronson N; Groen HJ
    Lung Cancer; 2001; 33(2-3):289-98. PubMed ID: 11551424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
    Curran MP; Plosker GL
    Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?
    Gridelli C
    Lung Cancer; 2002 Nov; 38 Suppl 2():S45-50. PubMed ID: 12431829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms.
    Thatcher N; Anderson H; Betticher DC; Ranson M
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():39-48. PubMed ID: 8718424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine in non-small cell lung cancer.
    Crinò L; Cappuzzo F
    Expert Opin Pharmacother; 2002 Jun; 3(6):745-53. PubMed ID: 12036414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.
    Harper P
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):2-12. PubMed ID: 12917815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
    Gridelli C; Perrone F; Gallo C; Cigolari S; Rossi A; Piantedosi F; Barbera S; Ferraù F; Piazza E; Rosetti F; Clerici M; Bertetto O; Robbiati SF; Frontini L; Sacco C; Castiglione F; Favaretto A; Novello S; Migliorino MR; Gasparini G; Galetta D; Iaffaioli RV; Gebbia V;
    J Natl Cancer Inst; 2003 Mar; 95(5):362-72. PubMed ID: 12618501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.